{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:38:45Z","timestamp":1712709525701},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,9]]},"DOI":"10.7759\/cureus.57902","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T14:18:40Z","timestamp":1712672320000},"source":"Crossref","is-referenced-by-count":0,"title":["Becoming Endemic: Anaplasmosis Imported Across State Borders"],"prefix":"10.7759","author":[{"given":"Joseph D","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather S","family":"Wenning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniyal A","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armo","family":"Derbarsegian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry A","family":"Brook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peimei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1112.050898","article-title":"Human granulocytic anaplasmosis and Anaplasma phagocytophilum","volume":"11","author":"Dumler JS","year":"2005","unstructured":"Dumler JS, Choi KS, Garcia-Garcia JC, et al.. Human granulocytic anaplasmosis and Anaplasma phagocytophilum. Emerg Infect Dis. 2005, 11:1828-34. 10.3201\/eid1112.050898","journal-title":"Emerg Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(03)00083-x","article-title":"The natural history of ticks","volume":"86","author":"Anderson JF","year":"2002","unstructured":"Anderson JF. The natural history of ticks. Med Clin North Am. 2002, 86:205-18. 10.1016\/s0025-7125(03)00083-x","journal-title":"Med Clin North Am"},{"key":"ref3","unstructured":"Anaplasmosis. (2022). Accessed. July 30, 2023: https:\/\/www.cdc.gov\/anaplasmosis\/index.html."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2011.09.008","article-title":"Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts","volume":"87","author":"Weil AA","year":"2012","unstructured":"Weil AA, Baron EL, Brown CM, Drapkin MS. Clinical findings and diagnosis in human granulocytic anaplasmosis: a case series from Massachusetts. Mayo Clin Proc. 2012, 87:233-9. 10.1016\/j.mayocp.2011.09.008","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1001\/jama.1996.03530270039029","article-title":"Clinical and laboratory characteristics of human granulocytic ehrlichiosis","volume":"275","author":"Bakken JS","year":"1996","unstructured":"Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA. 1996, 275:199-205.","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2022.2039046","article-title":"Anaplasmosis-induced hemophagocytic lymphohistiocytosis","volume":"35","author":"de Jesus M","year":"2022","unstructured":"de Jesus M, Lopez A, Yabut J, Vu S, Manne M, Ibrahim L, Mutneja R. Anaplasmosis-induced hemophagocytic lymphohistiocytosis. Proc (Bayl Univ Med Cent). 2022, 35:379-81. 10.1080\/08998280.2022.2039046","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser GP","year":"2006","unstructured":"Wormser GP, Dattwyler RJ, Shapiro ED, et al.. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006, 43:1089-134. 10.1086\/508667","journal-title":"Clin Infect Dis"},{"key":"ref8","unstructured":"Ohio vectorborne disease surveillance update. (2019). Accessed. July 30, 2023: https:\/\/u.osu.edu\/zika\/2019\/07\/10\/ohio-vectorborne-disease-surveillance-update\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad193","article-title":"Anaplasmosis in Pennsylvania: clinical features, diagnosis, and outcomes of patients diagnosed with Anaplasma phagocytophilum infection at Hershey Medical Center from 2008 to 2021","volume":"10","author":"Ingram D","year":"2023","unstructured":"Ingram D, Joseph B, Hawkins S, Spain J. Anaplasmosis in Pennsylvania: clinical features, diagnosis, and outcomes of patients diagnosed with Anaplasma phagocytophilum infection at Hershey Medical Center from 2008 to 2021. Open Forum Infect Dis. 2023, 10:ofad193. 10.1093\/ofid\/ofad193","journal-title":"Open Forum Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10071433","article-title":"Human granulocytic anaplasmosis-a systematic review of published cases","volume":"10","author":"Dumic I","year":"2022","unstructured":"Dumic I, Jevtic D, Veselinovic M, et al.. Human granulocytic anaplasmosis-a systematic review of published cases. Microorganisms. 2022, 10:1433. 10.3390\/microorganisms10071433","journal-title":"Microorganisms"},{"key":"ref11","unstructured":"Tickborne diseases. ( 2023). Accessed. July 30, 2023: https:\/\/www.alleghenycounty.us\/Health-Department\/Resources\/Data-and-Reporting\/Infectious-Disease-Epidemiology\/Tickbor...."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12890\/2021_003047","article-title":"Human granulocytic anaplasmosis as a COVID-19 mimicker","volume":"8","author":"Ramanujam D","year":"2021","unstructured":"Ramanujam D, Nasrullah A, Bahr M, Ashraf O, Malik K. Human granulocytic anaplasmosis as a COVID-19 mimicker. Eur J Case Rep Intern Med. 2021, 8:003047. 10.12890\/2021_003047","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis852","article-title":"Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity","volume":"56","author":"Horowitz HW","year":"2013","unstructured":"Horowitz HW, Aguero-Rosenfeld ME, Holmgren D, McKenna D, Schwartz I, Cox ME, Wormser GP. Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis. 2013, 56:93-9. 10.1093\/cid\/cis852","journal-title":"Clin Infect Dis"},{"key":"ref14","article-title":"Features of clinical manifestations of human granulocytic anaplasmosis in the Western region of Ukraine","volume":"8","author":"Ben I","year":"2019","unstructured":"Ben I. Features of clinical manifestations of human granulocytic anaplasmosis in the Western region of Ukraine. Pharm Innov. 2019, 8:118-22.","journal-title":"Pharm Innov"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/244196-becoming-endemic-anaplasmosis-imported-across-state-borders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T14:18:45Z","timestamp":1712672325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/244196-becoming-endemic-anaplasmosis-imported-across-state-borders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,9]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.57902","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,9]]}}}